Trial Scorecards
Trial Scorecards
December 11, 2019
1 min read
Save

ORION-10

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Safety, efficacy and tolerability of inclisiran (The Medicines Company) in patients with atherosclerotic CVD and elevated LDL despite optimal medical therapy.

Trial Scorecard: ORION-10